本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Psyence Biomedical Ltd

1.76
-0.0500-2.76%
盤後1.770.0100+0.57%19:50 EST
成交量:6.19萬
成交額:11.09萬
市值:328.63萬
市盈率:-0.32
高:1.85
開:1.81
低:1.76
收:1.81
52周最高:62.72
52周最低:1.41
股本:186.72萬
流通股本:185.98萬
量比:0.30
換手率:3.33%
股息:- -
股息率:- -
每股收益(TTM):-5.5651
每股收益(LYR):5.24
淨資產收益率:-74.29%
總資產收益率:-34.44%
市淨率:0.28
市盈率(LYR):0.34

資料載入中...

2025/10/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/10/06

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/07/25

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/07/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/25

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/13

SEC問詢函

Form CORRESP - Correspondence
2025/01/28

SEC問詢函

Form CORRESP - Correspondence
2025/01/24

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/12/30

SEC問詢函

Form CORRESP - Correspondence
2024/12/20

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/12/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/09

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/12/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

SEC問詢函

Form CORRESP - Correspondence
2024/10/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/10/08

SEC問詢函

Form CORRESP - Correspondence
2024/10/02

招股説明書

Form F-1 - Registration statement for certain foreign private issuers